drugset / Trial / NCT05446324
Feasibility of Gallium-68-tilmanocept PET/CT for Sentinel Lymph Node Detection in Endometrial Cancer
NaSingle-groupOpen-labelDiagnostic
Summary
This pilot study evaluates the feasibility of 68Ga-tilmanocept PET/CT for SLN mapping in patients with endometrial cancer.
Timeline
- Start
- 2023-02-15
- Primary completion
- 2024-07-01
- Completion
- 2024-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gallium-68-tilmanocept | Diagnostic / imaging agent | 10 mbq | Other |